Merck treads water in Q4 as Keytruda helps offset Remicade suffering

Tracy Staton Merck & Co. took a one-two punch in the fourth quarter. Revenue from two top-selling franchises–Januvia and Remicade–slid, dragging overall ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS